Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.05B | 3.18B | 2.83B | 2.94B | 2.86B | 2.52B |
Gross Profit | 1.03B | 1.06B | 948.20M | 954.60M | 957.30M | 813.30M |
EBITDA | -3.20M | 140.10M | 420.20M | 401.50M | 546.50M | 330.40M |
Net Income | -266.50M | -211.00M | 569.70M | 208.90M | 249.90M | -53.40M |
Balance Sheet | ||||||
Total Assets | 4.81B | 5.24B | 5.55B | 3.87B | 4.01B | 3.99B |
Cash, Cash Equivalents and Short-Term Investments | 458.40M | 199.30M | 242.90M | 234.10M | 446.10M | 302.20M |
Total Debt | 1.99B | 2.03B | 2.10B | 1.31B | 1.32B | 1.67B |
Total Liabilities | 3.44B | 3.78B | 3.88B | 2.76B | 2.78B | 2.91B |
Stockholders Equity | 1.36B | 1.42B | 1.63B | 1.08B | 1.21B | 1.06B |
Cash Flow | ||||||
Free Cash Flow | 153.60M | 137.10M | 137.70M | 140.80M | 488.40M | 318.90M |
Operating Cash Flow | 202.10M | 191.30M | 207.00M | 191.10M | 528.40M | 354.80M |
Investing Cash Flow | 35.20M | 26.80M | -729.90M | -143.40M | 126.00M | -1.30B |
Financing Cash Flow | -84.90M | -227.10M | 693.40M | -244.20M | -523.30M | 854.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $1.51B | 22.61 | 11.04% | 1.46% | 1.35% | -40.63% | |
69 Neutral | $997.87M | 22.44 | 12.06% | 1.95% | 0.92% | 21.96% | |
69 Neutral | $1.97B | 32.26 | 9.29% | 0.78% | 2.67% | -18.41% | |
65 Neutral | $10.75B | 15.72 | 5.20% | 1.90% | 3.09% | -27.42% | |
59 Neutral | $1.76B | ― | -15.50% | ― | 19.35% | 27.83% | |
50 Neutral | $1.60B | ― | -18.22% | 3.96% | 0.31% | -423.59% | |
45 Neutral | $1.89B | ― | -27.40% | ― | 18.32% | -712.12% |
On July 9, 2025, Hillenbrand, Inc. entered into a Fifth Amended and Restated Credit Agreement with JPMorgan Chase Bank and J.P. Morgan SE, among others. The new Credit Agreement revises the previous one from June 8, 2022, reducing the revolving credit facility from $1 billion to $700 million, with an option to increase by $600 million. It includes two term loan facilities: a $175 million U.S. Dollar-denominated term loan and a €240 million Euro-denominated term loan. These facilities aim to refinance existing debts and support general corporate purposes. The agreement includes various covenants and conditions, such as maximum leverage ratios and interest coverage ratios, and allows for extensions of the maturity date. The changes in the credit structure are expected to impact Hillenbrand’s financial flexibility and operational strategies.
The most recent analyst rating on (HI) stock is a Buy with a $50.00 price target. To see the full list of analyst forecasts on Hillenbrand stock, see the HI Stock Forecast page.
Hillenbrand, Inc. announced the departure of Robert VanHimbergen as Chief Financial Officer, effective June 27, 2025, and the appointment of Megan Walke as Interim CFO starting June 28, 2025. Ms. Walke, who has been with the company since 2011, will also continue her roles as Vice President, Corporate Controller, and Chief Accounting Officer. The company is still searching for a permanent CFO replacement, and Ms. Walke has entered into a Change in Control Agreement similar to those of other executive officers.
The most recent analyst rating on (HI) stock is a Buy with a $50.00 price target. To see the full list of analyst forecasts on Hillenbrand stock, see the HI Stock Forecast page.
On May 12, 2025, Hillenbrand‘s CFO, Robert M. VanHimbergen, announced his decision to leave the company effective June 27, 2025, to pursue another position. His departure is not due to any disagreements with the company. Megan Walke, the current Vice President, Corporate Controller, and Chief Accounting Officer, will serve as Interim CFO while the company searches for a permanent replacement. Hillenbrand’s leadership, including CEO Kim Ryan, acknowledged VanHimbergen’s contributions in transforming the company into a pure-play industrial entity and expressed confidence in the company’s strategic positioning and competitive edge in the industry.
The most recent analyst rating on (HI) stock is a Buy with a $50.00 price target. To see the full list of analyst forecasts on Hillenbrand stock, see the HI Stock Forecast page.
On April 29, 2025, Hillenbrand reported a 9% decrease in revenue for the fiscal second quarter ending March 31, 2025, primarily due to lower volume in the Advanced Process Solutions segment. The company completed the sale of its majority stake in the Milacron injection molding and extrusion business, using the proceeds to reduce debt and focus on more profitable sectors. Despite a challenging macroeconomic environment with increased tariffs and uncertainty, Hillenbrand remains optimistic about its long-term growth prospects and competitive positioning.